ScholarIQanswers from OpenAlex

Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice

PaperCitations, authors & open-access status

Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice have?

ScholarIQcitation count

Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice has 173 citations in the OpenAlex counts ScholarIQ stores.

When was Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice published?

ScholarIQyear

Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice has 2016 year in the ScholarIQ index.

What is the open-access status of Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice?

ScholarIQoa status

Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice has gold oa status in the ScholarIQ index.

What is the DOI of Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice?

ScholarIQdoi

The DOI for Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice is on the source record.

What is the PMID of Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice?

ScholarIQpmid

The PMID for Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice is on the source record.

What is the OpenAlex record for Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice?

ScholarIQopenalex

The OpenAlex for Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial